PTP4A3

PTP4A3
Available structures
PDB	Ortholog search: PDBe RCSB
List of PDB id codes
	1R6H, 1V3A, 2MBC
Identifiers
Aliases	PTP4A3, PRL-3, PRL-R, PRL3, protein tyrosine phosphatase type IVA, member 3, protein tyrosine phosphatase 4A3
External IDs	OMIM: 606449; MGI: 1277098; HomoloGene: 22500; GeneCards: PTP4A3; OMA:PTP4A3 - orthologs
Gene location (Human)
Chr.	Chromosome 8 (human)
End	141,432,454 bp
Gene location (Mouse)
Chr.	Chromosome 15 (mouse)
End	73,630,615 bp
RNA expression pattern
	Top expressed in
	apex of heart; ; gastric mucosa; ; muscle of thigh; ; left ventricle; ; gastrocnemius muscle; ; right auricle; ; skeletal muscle tissue; ; anterior pituitary; ; tibial arteries; ; right coronary artery;
	Top expressed in
	muscle of thigh; ; extensor digitorum longus muscle; ; blood; ; plantaris muscle; ; medial head of gastrocnemius muscle; ; tibialis anterior muscle; ; neural layer of retina; ; digastric muscle; ; knee joint; ; triceps brachii muscle;
	More reference expression data
	; ; ; ;
	More reference expression data
Gene ontology
Molecular function	protein tyrosine phosphatase activity; prenylated protein tyrosine phosphatase activity; phosphatase activity; phosphoprotein phosphatase activity; hydrolase activity; protein tyrosine/serine/threonine phosphatase activity; protein binding;
Cellular component	endosome; plasma membrane; early endosome; membrane; nucleus; cytoplasm;
Biological process	Notch signaling pathway; protein dephosphorylation; positive regulation of vascular permeability; regulation of vascular endothelial growth factor signaling pathway; endothelial cell migration; dephosphorylation; peptidyl-tyrosine dephosphorylation; regulation of transcription, DNA-templated; positive regulation of NIK/NF-kappaB signaling; positive regulation of establishment of protein localization; cellular response to leukemia inhibitory factor;
	Sources:Amigo / QuickGO
Orthologs
	11156
	19245
	ENSG00000184489; ENSG00000275575
	ENSMUSG00000059895
	O75365
	Q9D658
	NM_007079; NM_032611
	NM_001166388; NM_001166389; NM_001166390; NM_008975; NM_001357591
	NP_009010; NP_116000
	NP_001159860; NP_001159861; NP_001159862; NP_033001; NP_001344520
	Wikidata
View/Edit Human	View/Edit Mouse

Protein tyrosine phosphatase type IVA 3 is an enzyme that in humans is encoded by the PTP4A3 gene.^[5]

The protein encoded by this gene belongs to a small class of prenylated protein tyrosine phosphatases (PTPs). PTPs are cell signaling molecules that play regulatory roles in a variety of cellular processes. This class of PTPs contain a PTP domain and a characteristic C-terminal prenylation motif. Studies of this class of PTPs in mice demonstrated that they were prenylated proteins in vivo, which suggested their association with cell plasma membrane. Overexpression of this gene in mammalian cells was reported to inhibit angiotensin-II induced cell calcium mobilization and promote cell growth. Two alternatively spliced variants exist.^[5]

References

^ ^a ^b ^c ENSG00000275575 GRCh38: Ensembl release 89: ENSG00000184489, ENSG00000275575 – Ensembl, May 2017
^ ^a ^b ^c GRCm38: Ensembl release 89: ENSMUSG00000059895 – Ensembl, May 2017
^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ ^a ^b "Entrez Gene: PTP4A3 protein tyrosine phosphatase type IVA, member 3".

Zeng Q, Hong W, Tan YH (1998). "Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1". Biochem. Biophys. Res. Commun. 244 (2): 421–7. doi:10.1006/bbrc.1998.8291. PMID 9514946.
Dayton MA, Knobloch TJ (1998). "Multiple phosphotyrosine phosphatase mRNAs are expressed in the human lung fibroblast cell line WI-38". Receptors & signal transduction. 7 (4): 241–56. PMID 9633825.
Zeng Q; Si X; Horstmann H; et al. (2000). "Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome". J. Biol. Chem. 275 (28): 21444–52. doi:10.1074/jbc.M000453200. PMID 10747914. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Matter WF; Estridge T; Zhang C; et al. (2001). "Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling". Biochem. Biophys. Res. Commun. 283 (5): 1061–8. doi:10.1006/bbrc.2001.4881. PMID 11355880. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Saha S; Bardelli A; Buckhaults P; et al. (2001). "A phosphatase associated with metastasis of colorectal cancer". Science. 294 (5545): 1343–6. doi:10.1126/science.1065817. PMID 11598267. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Wang J, Kirby CE, Herbst R (2003). "The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum and the mitotic spindle and is required for normal mitosis". J. Biol. Chem. 277 (48): 46659–68. doi:10.1074/jbc.M206407200. PMID 12235145.
Strausberg RL; Feingold EA; Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Pathak MK; Dhawan D; Lindner DJ; et al. (2003). "Pentamidine is an inhibitor of PRL phosphatases with anticancer activity". Mol. Cancer Ther. 1 (14): 1255–64. PMID 12516958. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Zeng Q; Dong JM; Guo K; et al. (2003). "PRL-3 and PRL-1 promote cell migration, invasion, and metastasis". Cancer Res. 63 (11): 2716–22. PMID 12782572. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Bardelli A; Saha S; Sager JA; et al. (2004). "PRL-3 expression in metastatic cancers". Clin. Cancer Res. 9 (15): 5607–15. PMID 14654542. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Kozlov G; Cheng J; Ziomek E; et al. (2004). "Structural insights into molecular function of the metastasis-associated phosphatase PRL-3". J. Biol. Chem. 279 (12): 11882–9. doi:10.1074/jbc.M312905200. PMID 14704153. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Kim KA; Song JS; Jee J; et al. (2004). "Structure of human PRL-3, the phosphatase associated with cancer metastasis". FEBS Lett. 565 (1–3): 181–7. doi:10.1016/j.febslet.2004.03.062. PMID 15135076. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Wu X; Zeng H; Zhang X; et al. (2004). "Phosphatase of Regenerating Liver-3 Promotes Motility and Metastasis of Mouse Melanoma Cells". Am. J. Pathol. 164 (6): 2039–54. doi:10.1016/S0002-9440(10)63763-7. PMC 1615773. PMID 15161639. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Gerhard DS; Wagner L; Feingold EA; et al. (2004). "The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Kato H; Semba S; Miskad UA; et al. (2005). "High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases". Clin. Cancer Res. 10 (21): 7318–28. doi:10.1158/1078-0432.CCR-04-0485. PMID 15534108. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Li J; Guo K; Koh VW; et al. (2005). "Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases". Clin. Cancer Res. 11 (6): 2195–204. doi:10.1158/1078-0432.CCR-04-1984. PMID 15788667. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Polato F; Codegoni A; Fruscio R; et al. (2006). "PRL-3 phosphatase is implicated in ovarian cancer growth". Clin. Cancer Res. 11 (19 Pt 1): 6835–9. doi:10.1158/1078-0432.CCR-04-2357. PMID 16203771. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Peng L; Jin G; Wang L; et al. (2006). "Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3". Biochem. Biophys. Res. Commun. 342 (1): 179–83. doi:10.1016/j.bbrc.2006.01.102. PMID 16472776. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Rouleau C; Roy A; St Martin T; et al. (2006). "Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function". Mol. Cancer Ther. 5 (2): 219–29. doi:10.1158/1535-7163.MCT-05-0289. PMID 16505094. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
Radke I; Götte M; Kersting C; et al. (2006). "Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer". Br. J. Cancer. 95 (3): 347–54. doi:10.1038/sj.bjc.6603261. PMC 2360632. PMID 16832410. {{cite journal}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)

[refGRCh38Ensembl-1] ENSG00000275575 GRCh38: Ensembl release 89: ENSG00000184489, ENSG00000275575 – Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000059895 – Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[entrez-5] "Entrez Gene: PTP4A3 protein tyrosine phosphatase type IVA, member 3".

[1]

[2]

[3]

[4]

[5]

References

Further reading